Common Side Effects Nausea (most common, peaks during dose escalation) Diarrhea, constipation, vomiting Decreased appetite, fatigue, headache Injection-site reactions (injectable forms) Rare: pancreatitis, gallbladder disease, kidney injury FDA boxed warning for medullary thyroid carcinoma (do not use with personal or family history of MTC or MEN2) How to Start GLP-1 Treatment See a clinician in-person primary care, endocrinology, obesity medicine, or US telehealth
Cada lote de BPC-157 + TB-500 se verifica por HPLC (pureza 99%) y espectrometra de masas para confirmar identidad
Why choose Well Medical Arts over an online weight loss provider
Research Status and Compliance Note Neither BPC-157 nor TB-500 is approved for human therapeutic use
Inspection of the trajectory of weight loss with time showed that weight loss with retatrutide was evident after 4-8 weeks and progressed with no evidence of plateau to the end of follow-up at 48 weeks [3]